Qu Biologics is a Vancouver-based, private, clinical stage biotechnology company developing Site Specific Immunomodulators (SSI), a novel proprietary immunotherapy platform. SSIs are designed to stimulate an innate immune response in targeted organs or tissues to reverse the chronic inflammation underlying many diseases including cancer and inflammatory bowel disease (Crohn's disease, ulcerative colitis). SSIs aim to restore immune function and have potential broad applicability across a wide variety chronic diseases. The company has initiated three clinical trials in Crohn's disease, ulcerative colitis and lung cancer.
Backed by a prestigious group of scientific advisors and board members, Qu Biologics is led by a management team that includes co-founder and CEO Dr. Hal Gunn, a physician and expert on the body's immune response to chronic disease and Chief Medical Officer Dr. Simon Sutcliffe, former CEO of the BC Cancer Agency and a distinguished clinician, scientist and leader in cancer control internationally.
We are always interested in talented biotechnology professionals and know that some of the best team members can be found when you’re not looking for them. For Qu, finding the right team member is not about matching a resume to a checklist of skills, it’s about integrity and character. If you have big ideas, love a fast-paced innovative environment and you’re up for the challenge, we want to hear from you. Send us your resume and a detailed cover letter telling us about yourself and how you feel you could contribute. Applications can be sent, in confidence, to jobs@qubiologics.com.
Company Details
- Employees
- 18
- Founded
- -
- Address
- 4475 Wayburne Dr, Suite 305,canada
- Phone
- (604) 734-1450
- ju****@****ics.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- qubiologics.com
- Keywords
- biotechnology, ulcerative colitis, Crohn's disease, arthritis, cancer, autoimmune diseases, autoimmune disorders, inflammatory bowel disease, IBD, Site Specific Immunomodulators, immunotherapies, investigational drug, pharmaceuticals, research, inflammation, biotech, clinical trials, innate immunity, COVID, biologics.
- HQ
- Burnaby, British Columbia
Qu Biologics Inc. Questions
Qu Biologics Inc.'s helpline number is (604) 734-1450
Qu Biologics Inc.'s website is qubiologics.com
Qu Biologics Inc.'s LinkedIn profile is https://ca.linkedin.com/company/qu-biologics-inc
Qu Biologics Inc. has
18 employees.
View email and phone details for 18
employees at Qu Biologics Inc..
Qu Biologics Inc.'s industry is
Biotechnology Research
Qu Biologics Inc.'s top competitors are
Stemcell Technologies,
Bold Therapeutics Inc.,
Acuitas Therapeutics,
Signalchem Biotech Inc.,
Abcellera,
Aspect Biosystems,
Symvivo Corporation,
Virogin Biotech,
Voxcell Bioinnovation,
Zymeworks Inc..
Qu Biologics Inc.'s support email address is julie@qubiologics.com
Qu Biologics Inc.'s categories are Biotechnology Research
Qu Biologics Inc.'s founding year is 2007
